	A Generalizable and Interpretable Framework for Molecular Subtype Classification of Pancreatic Ductal Adenocarcinoma Integrating Conformal Uncertainty Quantification and Consensus-Based Explainable Artificial Intelligence Across Multiple Cohorts. Int J Mol Sci Yasar S, Yagin FH, Alzakari SA, Alkhalifa AK, Al-Hashem F, Tabnjh AK. PMID: 42589641 [PubMed - indexed for MEDLINE]
	PARP Inhibitor Sensitivity in Tumors Harboring Non-BRCA Homologous Recombination Gene Alterations: Current Evidence Across Ovarian, Breast, Prostate, and Pancreatic Cancers. Int J Mol Sci Dos Santos ES, Cicilini AL, Simões MFE, Baz M, Caputo SM, Rouleau E. PMID: 42589411 [PubMed - indexed for MEDLINE]
	Preclinical Optimization of Magnetotactic Bacteria Therapy for the Treatment of Pancreatic and Rectal Cancer. Cancers (Basel) Tremblay C, Dutra MS, Soulez G, Martel S, Batist G, Miller CS. PMID: 42588645 [PubMed]
	Cancer Risk Profile of the Levonorgestrel-Releasing Intrauterine Device: A Narrative Review. Cancers (Basel) Akgör U, Temiz BE, Ege HV, Ellis LB, Bowden S, Kyrgiou M, Arbyn M, Preti M, Chatzistamatiou K, Razumova Z, Kesic V, Bizzarri N, Gassama O, Hemida R, Ibraheem N, El Hajj H, Raina D, Collinet P, Krämer B, Gultekin M. PMID: 42588595 [PubMed]
	A Clinical Score to Identify Individuals at High Risk of Pancreatic Cancer in the General Population. Diagnostics (Basel) Lee HJ, Oh JS, Kim S, Park SW, Oh D, Song TJ, Kim GU, Choi JY, Lee JS, Chang HS, Lee JY. PMID: 42587626 [PubMed]
	Distal vs. total pancreatectomy with celiac axis resection in patients with locally advanced/borderline resectable pancreatic carcinoma - a retrospective cohort study. BMC Surg Chrysos A, Amygdalos I, Eickhoff RM, Joechle K, Meister F, Hitpass L, Bruners P, Cammann S, Beetz O, Oldhafer F, von Websky M, Vogel T, Vondran FWR, Wiltberger G. PMID: 42587295 [PubMed - indexed for MEDLINE]
	Pretreatment geriatric nutritional risk index is associated with impaired treatment continuity and supportive care-relevant outcomes in unresectable pancreatic ductal adenocarcinoma. Support Care Cancer Shinohara N, Oe S, Miyagawa K, Honma Y, Kajitani K, Ueda T, Ogino N, Kumei S, Watanabe T, Shibata M, Harada M. PMID: 42587141 [PubMed - indexed for MEDLINE]
	NUP153 immunoreactivity in neuroendocrine neoplasms supports the diagnosis of NET versus NEC and is modulated by post-translational modifications. J Neuroendocrinol Mattern S, Ali A, Hollfoth V, Bag E, Kluthe K, Herpel E, Bergmann F, Muley T, Meister M, Lehmann-Koch J, Goeppert B, Warth A, Breuhahn K, Bonzheim I, Singer S, Singer K. PMID: 42586948 [PubMed - indexed for MEDLINE]
	Clinical outcomes and cost-effectiveness of surveillance for asymptomatic pancreatic head cystic neoplasms in adults aged 40-75: a microsimulation study. Pancreatology Gong A, Guo J, Sun S. PMID: 42586876 [PubMed - as supplied by publisher]
	A multi-scale fusion model based on multi-phase contrast-enhanced CT for predicting pancreatic cancer resectability. Phys Med Biol Cheng X, Liu Y, Li J, Ma J, Gao Y, Zhou C, Li S. PMID: 42586150 [PubMed - as supplied by publisher]
	From detection to clinical practice: Defining acceptable false-positive thresholds for pre-diagnostic pancreatic cancer detection. Clin Imaging Tixier F, Syailendra EA, Lopez-Ramirez F, Chu LC, Fishman EK. PMID: 42585777 [PubMed - as supplied by publisher]
	Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences. Mol Biomed Xu Y, Wang S, Sun G, Shen Y, Chang S, He P, Wu S, Yang S, Mao Y, Wang Z, Liu J, Wang T, Zhang B, Jiang K, Chen J, Huang H, Peng J, Xia X, Wu Y, Wang M, Xu S, Tao J, Chong L, Zhu J, Huang D, Jiang Y, Wang Y, Bao H, Wu X, Shao Y. PMID: 42584731 [PubMed - indexed for MEDLINE]
	Third-Line Treatment Timing After Second-Line Discontinuation in Advanced Pancreatic Cancer: A 30-Day Landmark Analysis. J Gastrointest Cancer Nagata K, Kajiura S, Sakumura M, Nakayama Y, Ueda Y, Motoo I, Ando T, Ogino B, Kawanaka H, Sakamoto J, Entani T, Hayashi N, Yasuda I. PMID: 42584721 [PubMed - indexed for MEDLINE]
	Real-world evidence in a large cohort comparing FAPI and FDG PET/CT for hepatopancreatobiliary cancer diagnosis. Eur J Nucl Med Mol Imaging Batchu S, Veenstra MMK, de Jong DM, Jayanthi MR, Vegt E, Memon SF, Tyagi A, Bos D, Lakhtakia S, Bruno MJ, Reddy DN, Rughwani H, Thomeer MGJ. PMID: 42584480 [PubMed - as supplied by publisher]
	Tumor Microenvironment-Responsive Nanoparticles for Pancreatic Cancer Imaging and Treatment. Int J Nanomedicine Qiu W, Li J, Cao Y, Zhou H, Hu H, Wang Z. PMID: 42583516 [PubMed - indexed for MEDLINE]
	CT-derived abdominal organ volumetrics for predicting recurrence-free and disease-free survival in resected non-small cell lung cancer: a multicenter retrospective cohort study. Transl Lung Cancer Res Huang H, Gong B, Lou J, Zhu D, Guo Y, Xiang G, Peng S, Li W, Li H, Yang L. PMID: 42582754 [PubMed]
	Solitary Peritoneal Metastasis of AFP-Negative Hepatocellular Carcinoma in a 65-Year-Old Man with a History of Lung Adenocarcinoma: A Case Report. Am J Case Rep Xie Z, Huang J, Fu K. PMID: 42581503 [PubMed - indexed for MEDLINE]
	Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer. Nat Med Aronchik I, Kar S, Zhuang Y, Ahler E, Lai LP, Seshadri V, Yang YC, Bulle A, Menard M, Nayak B, Labrecque MP, Dilly J, Kim E, Jiang L, Yano J, Wasko UN, Helland C, Bredeson S, Garrick B, Gindin Y, Sickler B, Wei X, Seamon K, Jiang J, Lim KH, Holderfield M, Quintana E, Hegde A, Salman Z, Starodub A, Spira A, Park W, Hong DS, Barve M, Pelster M, Sommerhalder D, Punekar SR, Garrido-Laguna I, Wolpin BM, Maitra A, Gustafson WC, Kelsey S, Smith JAM, Lin KK, Aguirre AJ, Singh M. PMID: 42581230 [PubMed - as supplied by publisher]
	Temperature-sensitive liquid embolic agent transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for BCLC Stage B/C hepatocellular carcinoma: a multicenter real-world study and spatial transcriptomics profiling (CHANCE 2515). Signal Transduct Target Ther Xie Q, Yang Y, Xie S, Yang X, Gao F, Qi W, Liu H, Liu Y, Deng J, Liu X, Zhou Y, Zhao X, Jiang K, Mao T, Liao X, Dai R, Lyu Y, Cai Y, Xie K, Wu H, Lan T, Liu C, CHANCE2515 Investigators. PMID: 42581040 [PubMed - indexed for MEDLINE]
	Precision targeting of stromal states in pancreatic cancer: a clinical perspective. Trends Cancer Wolters A, Bijlsma M, Prakash J. PMID: 42580968 [PubMed - as supplied by publisher]

Articles 1 - 20 / 61165

Page 1 of 3059



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy